The British government is now fighting a war on two fronts. The first is the external battle against the United States over a threatened 100% tariff on pharmaceuticals. The second is an internal, political battle to manage the fallout at home, where the government faces accusations of incompetence for allowing a critical industry to become so vulnerable.
The external front requires delicate and urgent diplomacy. Government officials are in intensive talks with their US counterparts, trying to secure an exemption before the October 1st deadline. This is a high-stakes negotiation where the economic future of a major UK sector hangs in the balance.
Simultaneously, the government must manage the domestic political front. The crisis has provided ammunition for opposition parties, who can point to the exclusion of pharma from the earlier trade deal as a major failure. The government will face tough questions in Parliament about why the industry was left unprotected and what its plan is to fix the situation.
The statement from a government spokesperson, acknowledging the “concerning” nature of the threat, is part of this two-front war. It is meant to reassure the domestic audience that the government is taking the problem seriously, while also serving as a public signal to the US about the gravity of the situation.
Successfully navigating this two-front war will require immense political skill. The government must be tough enough in its negotiations with the US to secure a good outcome, while also being transparent and accountable enough to maintain public and political support at home. A failure on either front could have severe consequences.